Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and Mortality
Journal of Gastroenterology and Hepatology · 2026-08 · 41 (8) · 2356-2364
DOI: 10.1111/jgh.70532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 01.07.2026. Verfasst von Yoon Suk Jung und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic …. Hauptthemen laut MEDLINE: Helicobacter Infections, Colorectal Neoplasms, Helicobacter pylori, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Research Foundation of Korea, Korea Medical Device Development Fund.
Abstract (Originalsprache)
Background and Aim Many studies have reported an association between Helicobacter pylori infection and an increased risk of colorectal cancer (CRC); however, the impact of eradication therapy on CRC remains unclear. We compared CRC incidence and mortality in individuals who received H. pylori treatment with those in the general population.
Methods
We conducted a population‐based study of 931 585 participants aged ≥ 20 years who received H. pylori eradication (HPE) therapy between 2009 and 2011. We used the one‐sample log‐rank test to compare standardized incidence ratios (SIRs) and standardized mortality ratios (SMRs) for CRC.
Results
The mean follow‐up period was 12.4 ± 1.1 years. CRC incidence and mortality rates were significantly lower in H. pylori –treated individuals than in the general population (total SIR: 0.66, 95% confidence intervals [CI] 0.64–0.67 and SMR: 0.51, 95% CI 0.49–0.54). Significant results were also observed in the 30–39, 40–49, 50–59, 60–69, and ≥ 70 age groups: The SIRs (95% CIs) were 0.80 (0.71–0.89), 0.73 (0.70–0.77), 0.62 (0.60–0.65), 0.66 (0.63–0.68), and 0.62 (0.59–0.66), respectively, and the SMRs (95% CIs) were 0.53 (0.36–0.76), 0.46 (0.39–0.54), 0.41 (0.37–0.46), 0.48 (0.44–0.53), and 0.65 (0.60–0.71), respectively. Similar results were observed when colon and rectal cancer were analyzed separately.
Conclusions
HPE may help reduce the risk and improve the survival from CRC. Its benefits may extend beyond preventing gastric cancer to CRC prevention. Our findings support the need for aggressive H. pylori screening and eradication treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea.
- Institute for Health and Society, Hanyang University, Seoul, Republic of Korea.
- Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea.
- Department of Internal Medicine, College of Medicine, Ewha Womans University, Seoul, Republic of Korea.
ORCID-Profile: Yoon Suk Jung, Chang Mo Moon
Förderung
- National Research Foundation of Korea
- Korea Medical Device Development Fund
Zitieren
APA
Jung, Y. S., Jeon, S., Park, B., & Moon, C. M. (2026). Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and Mortality. Journal of Gastroenterology and Hepatology, 41(8), 2356-2364. https://doi.org/10.1111/jgh.70532
Vancouver
Jung YS, Jeon S, Park B, Moon CM. Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and Mortality. Journal of Gastroenterology and Hepatology. 2026;41(8):2356-2364. doi:10.1111/jgh.70532
BibTeX
@article{Jung2026,
author = {Jung, Yoon Suk and Jeon, Somin and Park, Boyoung and Moon, Chang Mo},
title = {Preventive Effect of Helicobacter pylori Treatment on Colorectal Cancer Incidence and Mortality},
journal = {Journal of Gastroenterology and Hepatology},
year = {2026},
volume = {41},
number = {8},
pages = {2356--2364},
doi = {10.1111/jgh.70532}
}
EUVIMED